This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
395 posters, 1 audios, 13 topics, 29 sessions, 1,056 authors, 461 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
April 16 - 18, 2026 | Phoenix, Arizona

2317724
Fernando Cabrera, Todd M. Bertoch, Jessica C. McCoun, Harold S. Minkowitz, Susanne Vogt, Scott Haughie, Kathleen Ocasio, Jeffrey P. Smith
Viatris, Viatris, Morgantown, WV, USA, CenExel JBR, Salt Lake City, UT, USA, Viatris/Mylan Pharma UK Ltd, Viatris Inc., Canonsburg, PA, USA, Evolution Research Group, Bellaire, Texas, USA,
Scientific Abstracts > Acute Pain
Efficacy and Safety of MR-107A-02, a Novel Fast-Acting Formulation of Meloxicam, for the Treatment of Acute Moderate-to-Severe Pain Following Herniorrhaphy